发明申请
- 专利标题: RECOMBINANT TOXIN FRAGMENTS
- 专利标题(中): 重组毒素片段
-
申请号: US12369341申请日: 2009-02-11
-
公开(公告)号: US20100022751A1公开(公告)日: 2010-01-28
- 发明人: Clifford Charles Shone , Conrad Padraig Quinn , Keith Alan Foster , John Chaddock , Philip Marks , J. Mark Sutton , Patrick Stancombe , Jonathan Wayne
- 申请人: Clifford Charles Shone , Conrad Padraig Quinn , Keith Alan Foster , John Chaddock , Philip Marks , J. Mark Sutton , Patrick Stancombe , Jonathan Wayne
- 申请人地址: GB Abingdon GB Salisbury
- 专利权人: SYNTAXIN LIMITED,THE HEALTH PROTECTION AGENCY
- 当前专利权人: SYNTAXIN LIMITED,THE HEALTH PROTECTION AGENCY
- 当前专利权人地址: GB Abingdon GB Salisbury
- 优先权: GB9617671.4 19960823; GB9625996.5 19961213
- 主分类号: C07K14/33
- IPC分类号: C07K14/33 ; C07H21/04 ; C12P21/00
摘要:
A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.
公开/授权文献
- US08012491B2 Recombinant toxin fragments 公开/授权日:2011-09-06
信息查询